Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …

Coronavirus disease 2019 (COVID-19) can lead to ongoing symptoms such as
breathlessness, fatigue and muscle pain, which can have a substantial impact on an …

Background COVID-19 is known to be associated with increased risks of cognitive and
psychiatric outcomes after the acute phase of disease. We aimed to assess whether these …

One in ten severe acute respiratory syndrome coronavirus 2 infections result in prolonged
symptoms termed long coronavirus disease (COVID), yet disease phenotypes and …

Failure to recover following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
may have a profound impact on individuals who participate in high-intensity/volume exercise …

To date, there have been> 750 million reported cases of COVID-19 globally since the
pandemic began in early 2020. 1 In the UK, there have been> 1 million patients hospitalized …

Infection can trigger thrombotic events. After respiratory and other infections, people have a
3–6-fold increased risk of arterial thrombosis, such as myocardial infarction and ischaemic …

Several major epidemiological studies have been funded in the UK with the goal of better
understanding the epidemiology of persistent symptoms following SARS-CoV-2 infection …

Introduction Many adults hospitalised with COVID-19 have persistent symptoms such as
fatigue, breathlessness and brain fog that limit day-to-day activities. These symptoms can …

In The Lancet Infectious Diseases, Sizulu Moyo and colleagues2 report their findings from
the first national tuberculosis prevalence survey in South Africa, which is a very important …